Read + Share
Amedeo Smart
Independent Medical Education
Sciurba FC, Christenson SA, Rheault T, Bengtsson T, et al. Effect of Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine on Exacerbation Rate and Risk in Patients With Moderate to Severe COPD. Chest 2025;167:425-435.PMID: 39197510
Email
LinkedIn
Privacy Policy